White Biotechnology Market Report Scope & Overview:
The White Biotechnology Market was valued at USD 349.30 Billion in 2025 and is expected to reach USD 694.38 Billion by 2035, growing at a CAGR of 7.11% from 2026-2035.
The White Biotechnology Market is projected to expand at a steady pace through 2035, as manufacturers replace petrochemical processes with enzymes, microbial fermentation and renewable feedstocks. Industrial biotechnology supplies biofuels, bio-based chemicals, biodegradable polymers and specialty enzymes to energy, food, pharmaceutical and materials producers. Blending mandates, carbon reduction targets and rising crude oil and carbon costs are strengthening the economic case for bio-based routes. Advances in synthetic biology, strain engineering and process scale-up are lowering unit costs and widening the range of products that can be made biologically. North America holds the largest regional share, while Asia Pacific is anticipated to register the fastest growth.
⮞In October 2025, the International Energy Agency raised its forecast for growth in global liquid biofuel demand to 2030 by 50%. The revision reflects stronger policy support and expanding blending programs across major producing countries.

To Get More Information On White Biotechnology Market - Request Free Sample Report
White Biotechnology Market Trends:
-
Scale-up of precision fermentation capacity for food ingredients, chemicals and specialty proteins
-
Growing use of engineered enzymes in pharmaceutical synthesis and low-temperature industrial processing
-
Expansion of sustainable aviation fuel and renewable diesel capacity based on bio-derived feedstocks
-
Commercialization of bio-based monomers and polymers such as PLA, FDCA and bio-based butanediol
-
Integration of AI-guided strain design and metabolic engineering to shorten development cycles
U.S. White Biotechnology Market Outlook:
The U.S. White Biotechnology Market was valued at USD 102.05 Billion in 2025 and is expected to reach USD 206.83 Billion by 2035, growing at a CAGR of 7.32% from 2026-2035.
The U.S. White Biotechnology Market constitutes the largest national market, supported by the Renewable Fuel Standard, large corn and soybean processing capacity and an extensive base of enzyme and fermentation companies. Ethanol, biodiesel and renewable diesel producers account for a major portion of output, while bio-based chemicals and polymers are expanding from pilot to commercial scale. Federal procurement preferences, research funding and state-level incentives encourage adoption of bio-based products. Venture-backed start-ups and established chemical groups are building fermentation plants near agricultural feedstock supplies. Policy continuity, financing availability and feedstock logistics remain the principal determinants of investment decisions. Producers able to document low carbon intensity receive premium pricing.
⮞In March 2026, the U.S. Environmental Protection Agency finalized the 2026-2027 Renewable Fuel Standard volumes, setting the total applicable volume at 26.81 billion RINs for 2026. The rule provides a defined demand signal for biofuel producers over the coming compliance years.

White Biotechnology Market Segment Analysis:
-
By Product Type, the Biofuels segment dominated the White Biotechnology Market with approximately 36.88% share in 2025, while the Biochemicals segment is the fastest growing with a CAGR of approximately 11.01%.
-
By Application, the Bioenergy segment dominated the White Biotechnology Market with approximately 37.84% share in 2025, while the Food and Beverages segment is the fastest growing with a CAGR of approximately 9.35%.
-
By Technology, the Enzyme Engineering and Biocatalysis segment dominated the White Biotechnology Market with approximately 46.50% share in 2025, while the Fermentation segment is the fastest growing with a CAGR of approximately 8.85%.
-
By End-Use Industry, the Food and Beverage segment dominated the White Biotechnology Market with approximately 31.57% share in 2025, while the Pharmaceutical segment is the fastest growing with a CAGR of approximately 9.62%.
By Product Type, Biofuels Dominates the White Biotechnology Market and Biochemicals Grows Fastest
Biofuels occupy the leading position within product types, underpinned by long-established ethanol and biodiesel industries and by binding blending obligations in the United States, Brazil, the European Union and India. Producers benefit from mature feedstock supply chains, existing distribution networks and government support for low-carbon transport fuels. The segment is also broadening toward renewable diesel and sustainable aviation fuel, which command premium pricing and attract investment from refiners and airlines seeking to meet emission targets. Co-products such as protein feed and distillers grains improve plant economics. Plant upgrades that add carbon capture and renewable power further improve the carbon scores that determine fuel premiums.
Biochemicals are advancing at the quickest rate, as chemical manufacturers pursue drop-in and novel bio-based building blocks to meet customer demand for lower-carbon materials. Fermentation routes now produce succinic acid, butanediol, lactic acid, organic diacids and surfactants at commercial volumes, and several have reached cost parity with fossil equivalents in selected applications. Brand owners in packaging, textiles and personal care are signing offtake agreements that reduce investment risk, which encourages additional capacity. Licensing models further accelerate adoption by allowing producers to build plants without developing the underlying process. Companies with proprietary strains and process know-how are also licensing technology to partners in Asia and Latin America, which spreads capacity globally.
⮞The European Bioplastics association reported in December 2025 that global bio-based plastics capacity stood at 2.31 million tonnes in 2025 and is forecast to reach about 4.69 million tonnes in 2030. The projection shows the pace at which bio-based materials are moving into mainstream manufacturing.

By Application, Bioenergy Dominates the White Biotechnology Market and Food and Beverages Grows Fastest
The bioenergy application sector holds the maximum share due to higher volume consumption compared to any other end-use application and is backed up by the relevant government policies. Ethanol in gasoline, biodiesel, and hydrotreated vegetable oil in diesel as well as sustainable aviation fuels all require biological transformation of sugars, starches, oils, and residues. Mandates linked to carbon intensity score incentivize the usage of carbon capture technology, low carbon feedstock and enzymes. Crude oil price volatility impacts the margins, however, the regulatory need guarantees steady consumption in nearly all geographical areas. Airlines are also entering offtake deals for low carbon jet fuels, thus expanding bioenergy usage outside road transportation.
Food and beverages are expected to have the fastest growth rate thanks to precision fermentation, enzyme applications and production of natural ingredients. Food manufacturers employ enzymes to enhance yields and improve taste and longevity in dairy, baking, brewing and starch processing, while fermentation-produced sweeteners, proteins, flavoring and vitamins replace the extraction or chemical synthesis. The consumer preference for clean label and plant-based foods increases demand, as well as the supply stability provided by fermentation processes.
⮞Brazil raised its mandatory blends to 30% ethanol in gasoline and 15% biodiesel in diesel with effect from August 2025. The higher mandates expand the volume of fuel that must be sourced from biological conversion.
By Technology, Enzyme Engineering and Biocatalysis Dominates the White Biotechnology Market and Fermentation Grows Fastest
Enzyme engineering and biocatalysis holds the dominant technology position, owing to its relevance across detergents, food processing, textiles, pulp and paper, animal nutrition, biofuels and pharmaceutical synthesis. Enzymes operate under mild conditions, reduce energy and chemical use, and can be tailored through protein engineering and directed evolution to suit specific substrates. Established suppliers benefit from broad patent estates, global application laboratories and long-term customer relationships. Computational design and machine learning are shortening development timelines and enabling enzymes that tolerate higher temperatures, solvents and pH ranges. Suppliers maintain extensive strain and enzyme libraries that give them an advantage in custom development for large industrial customers.
Fermentation is poised for the fastest growth, supported by improvements in microbial hosts, bioreactor design and downstream separation. Industrial strains of yeast, bacteria and filamentous fungi are being engineered to convert sugars, waste gases and lignocellulosic residues into fuels, chemicals, proteins and polymers at larger scale. Investment in large-volume tanks, contract manufacturing and gas fermentation facilities is easing the capacity bottleneck that previously limited commercial launches. Falling sequencing and synthesis costs allow developers to iterate on strains more quickly and at lower cost. Government grants for biomanufacturing infrastructure further support the construction of new facilities in the United States, Europe and China.
⮞In August 2026, Codexis stated that it plans to reach full production at its GMP manufacturing center for enzymatic RNA synthesis by the end of 2027. The plan shows how engineered enzymes are being scaled for pharmaceutical manufacturing.
By End-Use Industry, Food and Beverage Dominates the White Biotechnology Market and Pharmaceutical Grows Fastest
Food and beverage represents the largest end-use industry, since enzymes, yeasts, cultures and fermentation-derived ingredients are embedded in dairy, baking, brewing, sweetener and starch processing. Demand is steady and diversified, and processors adopt biological solutions to raise yield, cut waste and reduce reliance on synthetic additives. Animal nutrition adds further volume through feed enzymes and amino acids that improve nutrient uptake and lower environmental impact. Regulatory approvals for new enzymes and microbial strains remain an important enabler for product launches within this industry. Starch processors and brewers continue to adopt newer enzyme generations to cut energy use and raw material costs.
Pharmaceutical manufacturers are the fastest-growing end users, as biocatalysis and fermentation are adopted for active ingredients, intermediates, antibiotics and nucleic acid therapies. Enzymatic routes deliver high selectivity, fewer synthesis steps and lower solvent consumption, which improves yield and reduces waste in regulated production. Growing biologics and oligonucleotide pipelines increase the need for scalable, high-purity biological processes. Drug makers are also engaging specialist enzyme suppliers through long-term development partnerships that embed biological manufacturing in new products. Contract development and manufacturing organizations are widening access to biological manufacturing for smaller drug developers that lack in-house capability.
⮞In February 2026, the European Commission adopted Implementing Regulation (EU) 2026/404, authorizing a 6-phytase feed additive for poultry and pigs. The authorization illustrates the regulatory pathway that governs enzyme products used in animal nutrition.
Regional Analysis:
|
Region |
Major Country |
Share within Region, 2025 (%) |
|---|---|---|
|
North America |
U.S. |
70.01 |
|
Europe |
Germany |
29.37 |
|
Asia Pacific |
China |
41.36 |
|
Latin America |
Brazil |
49.28 |
|
Middle East & Africa |
Saudi Arabia |
28.54 |
North America White Biotechnology Market Insights
North America commanded the largest regional share of 41.73% in 2025, a position attributed to the Renewable Fuel Standard, abundant corn and soybean supply and an established base of enzyme, fermentation and biofuel companies. The United States hosts the world's largest fuel ethanol sector and a growing set of bio-based chemical plants, and several producers are investing in carbon capture to lower the carbon intensity of their fuels. Strong venture funding and national laboratories support early-stage technologies, and large chemical groups are partnering with start-ups to scale production.
Canada contributes through biofuel production, forestry residue conversion and clean fuel regulations that require lower carbon intensity in transport fuels. Government programs support biomanufacturing facilities and agricultural feedstock development, particularly in the prairie provinces where canola, wheat and corn are abundant. Federal procurement preferences in the United States favor bio-based products, and a national commission has urged sustained public investment in biotechnology manufacturing. Financing conditions and shifts in federal policy nevertheless influence the timing of project decisions across the region. Universities and national laboratories supply skilled researchers to the sector.
⮞In June 2025, the U.S. Department of Agriculture issued the BioPreferred final rule, which merged the federal procurement and voluntary labeling frameworks for products covering more than 125 designated categories. The rule strengthens public demand for bio-based goods.

Get Customized Report as Per Your Business Requirement - Enquiry Now
Europe White Biotechnology Market Insights
Europe is a mature, policy-driven region in which Germany, France, the Netherlands, Denmark and the United Kingdom host leading enzyme, fermentation and bio-based chemical producers. The European Green Deal, the Renewable Energy Directive and aviation fuel mandates generate sustained demand for advanced biofuels and bio-based materials. Denmark and the Netherlands concentrate enzyme research and production, whereas Germany and France are home to large chemical groups and agricultural processors that are integrating biological routes into existing sites. Biorefinery projects in Finland, Sweden and Italy extend regional capacity for advanced biofuels and bio-based chemicals.
Regulation shapes the pace of commercialization, since novel food, feed additive and chemical approvals can take a long time to obtain, yet they also give approved suppliers a durable position. The region is investing in biorefineries that process agricultural and forestry residues, and several bio-based polymer and monomer plants are under construction or in start-up. High energy costs and competition from lower-cost imports pose challenges for producers, which has encouraged policymakers to introduce procurement preferences and offtake support for European manufacturers.
⮞In November 2025, the European Commission published its updated Bioeconomy Strategy, which plans a Bio-based Europe Alliance to mobilize corporate offtake commitments of about USD 11.6 billion by 2030. The initiative is intended to provide demand certainty for bio-based producers.
Asia Pacific White Biotechnology Market Insights
Asia Pacific is projected to be the fastest-growing region, advancing at a CAGR of 9.04% during 2026-2035, as governments back industrial biotechnology as a pillar of manufacturing strategy. China holds a dominant position in bio-fermentation output for amino acids, vitamins, organic acids and bio-based polyamides, and it continues to add capacity. India is building ethanol blending, bio-based chemical and enzyme capacity under national bioeconomy policies, while Japan, South Korea and Thailand focus on biopolymers, specialty enzymes and sugarcane-based chemicals.
Abundant agricultural feedstocks, large domestic markets and rising environmental standards are attracting both local champions and multinational producers. Southeast Asian countries such as Thailand and Indonesia combine sugar, cassava and palm resources with growing export demand for bio-based plastics and biofuels. Joint ventures between regional manufacturers and global technology licensors are accelerating plant construction. Differences in regulation, intellectual property enforcement and infrastructure across the region require tailored market entry strategies, and local partnerships remain critical. Government incentives for bio-based industries in several countries are reducing the risk of capital commitments for domestic and foreign investors.
⮞In April 2026, NatureWorks opened its integrated Ingeo biopolymer manufacturing facility in Nakhon Sawan, Thailand, with annual capacity of about 75,000 tonnes. The plant brings large-scale bio-based polymer production closer to Asian packaging and fiber customers.
MEA & Latin America White Biotechnology Market Insights
In the Middle East and Africa, interest centers on diversification away from hydrocarbons. Saudi Arabia and the United Arab Emirates are supporting biotechnology, bio-based plastics and sustainable aviation fuel projects under national economic visions, and Egypt is developing ethanol and agricultural residue conversion capacity. South Africa has an established sugar and biofuel base, and investors are examining large ethanol projects. Limited local feedstock in desert economies, water availability and the need for imported technology remain constraints. Gulf sovereign investors are also funding biotechnology ventures that target food security and materials production.
⮞In October 2025, Egypt's Prime Minister inaugurated the Kemet ethanol plant in the Sokhna Industrial Zone, which produces ethanol from molasses. The opening signals growing regional interest in bio-based production.
Latin America combines low-cost agricultural feedstocks with long experience in biofuels, and Brazil dominates regional output through its sugarcane ethanol industry and extensive flex-fuel vehicle fleet. Mexico, Argentina, Colombia and Chile add demand through biodiesel, ethanol and agricultural enzyme use. Brazilian producers are expanding corn ethanol, biogas and bio-based polymer capacity, and global brands are partnering with regional companies to secure renewable materials. Currency volatility and logistics costs can affect project returns, although feedstock abundance gives the region a durable cost advantage.
⮞Braskem reported in May 2025 that its I'm green bio-based polyethylene capacity had risen to 275,000 tonnes per year, up from 200,000 tonnes. The expansion confirms the region's role as a major supplier of bio-based plastics.
Market Dynamics:
Growth Drivers: Decarbonization Mandates, Cost Competitiveness and Synthetic Biology Advances Drive Growth in the White Biotechnology Market
Decarbonization mandates are the strongest force behind demand. Blending requirements for transport fuels, sustainable aviation fuel obligations and corporate commitments to reduce Scope 3 emissions create a durable market for bio-derived products. Governments are reinforcing these measures through tax credits, procurement preferences and research funding, and the resulting policy visibility allows developers to secure financing for large plants. Rising carbon prices and volatile crude oil markets also narrow the cost gap between fossil and bio-based alternatives. Public research funding for industrial biotechnology in the United States, the European Union and China supports pre-commercial development and lowers risk for early investors.
Technological progress adds a second source of momentum. Synthetic biology, protein engineering and AI-assisted strain design reduce development time and raise yields, which improves unit economics at commercial scale. Falling DNA sequencing and synthesis costs allow companies to test more variants, while advances in downstream processing lower separation costs that once limited adoption. Consumer and brand owner preference for renewable materials supports premium pricing for products such as bio-based plastics, natural ingredients and low-carbon chemicals. Cost reductions in sugar, cellulosic and waste-gas conversion allow developers to compete in commodity-scale markets rather than only in premium applications.
⮞The National Security Commission on Emerging Biotechnology reported in April 2025 that the United States should invest at least USD 15 billion over five years and made 49 recommendations to Congress. The report signals growing policy attention to biomanufacturing capacity.
Restraints: High Capital Requirements, Scale-Up Risk and Feedstock Volatility Restrain Growth in the White Biotechnology Market
Capital-intensive investment is still a big challenge. Fermentation, biorefinery and polymer plants have high initial investments, with many pioneering plants having delays in construction due to cost escalations. Lenders and investors usually demand government guarantees or long-term offtake agreements, which might not be available. Public funding leaves projects vulnerable to any shifts in policies, while competition from existing oil-based producers with fully depreciated capital structure impacts the price for products from the alternative sources. The sustainability requirements, like restriction on land usage changes, involve additional costs for biofuels and biochemicals manufacturers.
Scale-up and feedstock challenges impose further limitations. Process developed in lab-scale bioreactors can suffer from loss of productivity and instability in commercial-scale equipment; contamination, downstream purification and energy costs might decrease margins. Feedstock prices vary seasonally, depending on harvests, weather and policies, and there is competition among different applications for agricultural biomass (food, animal feed, chemicals), so it might increase inputs. Differing regulations by region make product approval and international trade complicated, which makes commercialization slower for small firms. Lack of skilled process engineers and insufficient contract fermentation capacities in some regions complicate scaling up to commercial production.
⮞In April 2026, Gevo withdrew its application for a Department of Energy loan guarantee for its alcohol-to-jet project and said it would seek other financing. The decision shows how funding conditions can delay advanced biofuel projects.
Opportunities: Sustainable Aviation Fuel, Bio-Based Polymers and Emerging Economies Create Opportunities in the White Biotechnology Market
Sustainable aviation fuel presents a major opportunity, since airlines face rising blending mandates and have limited alternatives for decarbonizing long-haul flights. Pathways based on ethanol-to-jet, hydroprocessed lipids and gas fermentation are attracting capital from refiners, airlines and fuel producers, and new plants are being commissioned in Europe, North America and Asia. Long-term offtake agreements with airlines are providing the revenue certainty needed for financing, and producers able to document low carbon intensity are expected to capture premium prices. Licensing agreements and co-investment structures allow technology owners to share capital requirements with regional partners.
Bio-based polymers and chemicals form a second avenue for growth as brand owners seek renewable packaging, textiles and coatings. Materials such as PLA, FDCA-based polyesters and bio-based polyethylene are moving from pilot toward commercial capacity, supported by regulations that restrict single-use plastics. Emerging economies in Asia, Latin America and the Middle East offer abundant feedstock, expanding industrial bases and supportive policies, and technology licensing allows local producers to enter the market without developing proprietary processes. Waste-based feedstocks such as used cooking oil, agricultural residues and industrial off-gases widen the resource base and strengthen the sustainability profile of new products.
⮞Neste reported in April 2025 that it had modified its Rotterdam refinery to produce up to 500,000 tonnes per year of sustainable aviation fuel, lifting its global capacity to 1.5 million tonnes per year. The upgrade demonstrates the scale of investment now directed at aviation biofuels.
Recent Developments:
-
In July 2025, Cargill and its joint venture Qore started production of QIRA bio-based 1,4-butanediol at Eddyville, Iowa, with annual capacity of 66,000 tonnes made from corn. The plant is among the largest bio-based chemical facilities to enter operation and supports demand for renewable materials in textiles and plastics.
-
In August 2025, Avantium started up the first part of its FDCA flagship plant in Delfzijl, the Netherlands, which is designed to produce up to 5,000 tonnes per year of furandicarboxylic acid. The start-up advances commercial supply of a bio-based building block for PEF packaging polymers.
-
In March 2025, Cathay Biotech formed a bio-based composites joint venture with CATL and Kalai Composites in China, with registered capital of 150 million yuan. The venture extends the company's bio-based polyamide business into lightweight composite materials.
-
In September 2026, Novonesis announced investment of about USD 700 million in a new enzyme production facility at Patalganga, India, scheduled to be fully operational in 2030. The facility expands regional capacity for enzymes used in biofuels, household care, and food and beverage processing.
-
In September 2026, Evonik announced additional fermentation capacity at its site in Slovenská Ľupča, Slovakia, with completion expected in early 2028. The expansion supports its biosurfactant and pharmaceutical intermediate fermentation products.
White Biotechnology Market Key Players:
-
Novonesis
-
BASF SE
-
International Flavors & Fragrances (IFF)
-
Cargill, Incorporated
-
Kerry Group plc
-
Evonik Industries AG
-
Corbion N.V.
-
Braskem S.A.
-
NatureWorks LLC
-
Avantium N.V.
-
Neste Corporation
-
Cathay Biotech Inc.
-
AB Enzymes (ABF Ingredients)
-
Amano Enzyme Inc.
-
Codexis, Inc.
-
Gevo, Inc.
-
Verbio SE
-
POET, LLC
-
Lesaffre
-
LanzaTech Global, Inc.
White Biotechnology Market Report Scope:
| Report Attributes | Details |
|---|---|
| Market Size in 2025 | USD 349.30 Billion |
| Market Size by 2035 | USD 694.38 Billion |
| CAGR | CAGR of 7.11% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (Biofuels, Biochemicals, Biomaterials, and Industrial Enzymes) • By Application (Bioenergy, Food and Beverages, Pharmaceuticals, Feed, and Other Applications) • By Technology (Enzyme Engineering and Biocatalysis, Fermentation, and Other Technologies) • By End-Use Industry (Food and Beverage, Pharmaceutical, Chemical and Industrial, and Other End-Use Industries) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
| Company Profiles | Novonesis, BASF SE, International Flavors & Fragrances (IFF), Cargill, Incorporated, Kerry Group plc, Evonik Industries AG, Corbion N.V., Braskem S.A., NatureWorks LLC, Avantium N.V., Neste Corporation, Cathay Biotech Inc., AB Enzymes (ABF Ingredients), Amano Enzyme Inc., Codexis, Inc., Gevo, Inc., Verbio SE, POET, LLC, Lesaffre, LanzaTech Global, Inc. |
Frequently Asked Questions
Some of the major companies operating in the White Biotechnology Market include Novonesis, BASF, IFF, Cargill, Kerry Group, Evonik Industries, Corbion, Braskem, NatureWorks, Avantium, Neste, Cathay Biotech, AB Enzymes, Amano Enzyme, Codexis, Gevo, Verbio, POET, Lesaffre and LanzaTech.
Key opportunities include sustainable aviation fuel, bio-based polymers and chemicals for packaging, textiles and coatings, and new bio-based capacity in emerging economies across Asia, Latin America and the Middle East.
Decarbonization mandates for transport fuels and materials, together with advances in synthetic biology and rising carbon and crude oil costs, are the key growth factors for the market.
By Product Type, the Biofuels segment dominated the White Biotechnology Market with approximately 36.88% share in 2025, supported by established ethanol and biodiesel industries and binding blending obligations in major economies.
North America dominated the White Biotechnology Market with a share of 41.73% in 2025, supported by the Renewable Fuel Standard, abundant feedstock supply and an established base of enzyme, fermentation and biofuel companies.